http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-066460-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-033
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
filingDate 2008-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-066460-A2
titleOfInvention COMPOUNDS DERIVED FROM PHENYL-PIPERAZINE, PHENYL-PIPERIDINE AND PHENYL-TETRAHIDROPIRIDINE AS INHIBITORS OF THE REABSORTION OF SEROTONIN, A PHARMACEUTICAL COMPOSITION AND USE OF THE SAME FOR THE PREPARATION OF MEDICINES
abstract Pharmaceutical composition and the use of such derivatives for the preparation of medicaments for the treatment of affective disorders, including depression, anxiety disorders that include general disorder and anxiety and panic disorder and obsessive compulsive disorder. Claim 1: A compound derived from phenyl-piperazine, phenyl-piperidine and phenyltetrahydropyridine represented by the general formula (1); in which Y is N, C or CH; X represents O or S; m is worth 1 or 2; p is worth 0,1, 2, 3, 4, 5, 6, 7 or 8; worth 0.1, 2, 3 or 4; s is worth 0, 1, 2, 3, 4 or 5; the dashed line represents an optional link; each of the R1, is selected, independently of the others, from the group represented by C1-6 alkyl, or two R1 attached to the same carbon atom can form a 3 to 6 membered spiro-fixed cycloalkyl; each of the R2 is selected, independently of the others, from the group represented by halogen, cyano, nitro, C1-6 alkyl / alkenyl / alkynyl, C1-6 alkyl / alkenyl / alkynyloxy, C1-6 alkyl / alkenyl / alkylsulfanyl, hydroxy, hydroxyalkyl / alkenyl / C1-6 alkynyl, haloalkyl / alkenyl / C1-6 alkynyl, haloalkyl / alkenyl / C1-6 alkyloxy, cycloalkyl / alkenyl / C3-8 alkynyl, cycloalkyl / alkenyl / C3-8 alkynyl / alkenyl / C1-6 alkynyl, acyl, C1-6 alkyl / alkenyl / alkyloxycarbonyl, C1-6 alkyl / alkenyl / alkylsulfonyl, or -NRxRy; -NRxCO-alkyl / alkenyl / C1-6 alkynyl; each of the R3, is selected, independently of the others, from the group represented by halogen, cyano, nitro, C1-6 alkyl / alkenyl / alkynyl, C1-6 alkyl / alkenyl / alkynyloxy, C1- alkyl / alkenyl / alkylsulfanyl 6, hydroxy, hydroxyalkyl / alkenyl / C1-6 alkynyl, haloalkyl / alkenyl / C1-6 alkynyl, haloalkyl / alkenyl / C1-6 alkyloxy, cycloalkenyl / C3-8 alkyl, cycloalkenyl / C3-8-a-alkyl / alkenyl / alkynyl -6, C1-6 alkyl / alkenyl / alkylsulfonyl, aryl, C1-6 alkyl / alkenyl / alkyloxycarbonyl, acyl, -NRxCO-alkyl / C1-6 alkenyl / alkynyl, -CONRxRy or NRxRy or, two R3 substituents together form a heterocycle fused to the phenyloselected ring from the group consisting of formulas (2) in which W is O or S; and R 'and Rö are hydrogen or C1-6 alkyl; or, two adjacent R3 substituents together form a fused heteroaromatic system containing 1, 2 or 3 heteroatoms, where each of the Rx and Ry is selected, independently of the others, from the group represented by hydrogen, alkyl / alkenyl / C1-alkynyl 6, C3-8 cycloalkyl / alkenyl, C3-8 cycloalkyl / alkenyl / C1-6 alkenyl / alkynyl, or aryl; or, Rx and Ry form together with the nitrogen atom to which they are attached, a ring of 3 to 7 members that optionally contain another heteroatom; or a pharmaceutically acceptable acid addition salt thereof.
priorityDate 2001-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410857516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18753234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414939035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414021234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722

Total number of triples: 50.